Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
35 Cards in this Set
- Front
- Back
Pharmacology
|
study of drugs, interactions with living systems, understanding physical, chemical properties, effects in the body, use of drugs, understanding how drugs are absorbed, distributed, metabolized and excreted.
|
|
Clinical Pharmacology
|
study of drugs in humans
|
|
Therapuetics
|
Pharmacotherapeutics): use of drugs to diagnose, prevent or treat disease, medical use.
|
|
Drug Names
|
1. Chemical name: chemical description
2. Generic name: non-proprietary name, given by United States Adopted Name Council. 3. Trade name: proprietary, created by drug companies, name approved by the FDA. |
|
Major Properties of an Ideal Drug
|
1. Effectiveness: elicits the intended response.
2. Safety: does not produce harmful effects. 3. Selectivity: produces only the response for which it is given. |
|
Therapeutic Objective
|
Provide maximum benefit with minimum harm.
|
|
Factors Determining the Intensity of Drug Responses
|
1. Administration: drug dosage, route of administration, timing of administration.
2. Pharmacokinetics: how the body affects the drug. Four pharmacokinetic processes: absorption, distribution, metabolism and excretion. 3. Pharmacodynamics: how the drug affects the body. Pharmacodynamic processes involve drug-receptor binding followed by the events that lead to the response. 4. Individual Variation: a. physiological factors b. pathophysiology c. genetic factors |
|
Pharmacokinetics
|
1. Absorption: mov’t of the drug from its site of administration into blood
2. Distribution: drug mov’t from blood to interstitial space of tissue and into the cells. 3. Metabolism: enzymatic processes that alter the drug 4. Excretion: movement of drug and metabolites out of the body. |
|
Drug Transport Across Cell Membranes
|
1. Direct penetration: crosses membrane by penetrating through it. Lipid soluble.
2. Transport systems: carry the drug across the membrane. Selective. P-glycoprotein - transports drugs out of cells 3. Passage through channels and pores: very small to pass through. |
|
Absorption
|
Mov’t of drug from its site of administration into the blood.
|
|
Bioavailability
|
extent to which a drug is absorbed and transported to the target tissue.
|
|
Factors that affect drug absorption
|
a. rate of dissolution: how easily drug dissolves. dissolves easy = quicker absorption.
b. surface area: the larger the surface area the quicker the drug will be absorbed. c. blood flow: absorbed quicker from sites with high blood flow d. lipid solubility: drugs with high lipid solubility are absorbed quicker e. pH partitioning: difference in the pH of the plasma and pH at the site of admin, greater the difference the more easily absorbed. f. site of absorption: absorption vary depending on the site of admin, route. |
|
Routes of Administration
|
a. intravenous: administered directly into the blood stream
b. intramuscular: injection into muscle, easily absorbed c. subcutaneous: injection into subcutaneous tissue. d. oral: absorbed from the stomach or the intestine. Barrier to absorption is the epithelial cells, transporter P-glycoprotein |
|
Advantages/Disadvantages of Intravenous
|
advantages: rapid onset, tight control over drug levels, can use large am’t of fluid disadvantages: dangerous – too fast, can’t take it back, inc risk of infection, cost
|
|
Advantages/Disadvantages of Intramuscular/Subcutaneous
|
advantages: used for meds that do not dissolve well, depot prep
disadvantages: painful, damage to local tissue, nerve damage. |
|
Oral absorption influenced by
|
1. food or delayed gastric emptying
2. drug interactions 3. coating 4. solubility of the drug, pH |
|
Advantages/Disadvantages of Oral
|
advantages: convenient, easier to use, less expensive.
disadvantags: inactivation or destruction of the drug, GI irritation, absorption variable from pt to pt. |
|
Oral formulations
|
1. tablets: mixture of drug plus binders and fillers
2. enteric-coated preparations: coated so will dissolve in intestines but not stomach. The coating protects drug or protect the stomach 3. sustained release preparations: capsules filled with coated spheres that contain the drug. coatings dissolve at variable rates e. other: topical – applied to the skin, eyes, nose, ears, vaginally, rectally, inhalation |
|
Distribution
|
Mov’t of drugs through the body
1. blood flow to the tissues: Drugs delivered by blood stream and rate of delivery determined by blood 2. ability of drug to exit the vascular system: exit at the capillary beds, easily pass between capillary cells except at: a. blood brain barrier: protects the brain from toxic substances. tight junctions between the capillary cells so through the cells – lipid soluble, med with transport system b. placenta: protective barrier. lipid soluble can pass 3. ability of drug to enter cells: lipid solubility and the presence of a transport system. some drugs do not cross cell membrane – bind with receptors. |
|
Metabolism
|
enzymatic alteration of the drug – referred to as the biotransformation. Occurs in the liver – the hepatic microsomal enzyme system. P450 system
|
|
Effects of Drug Metabolism
|
a. accelerated renal drug excretion: unable to excrete lipid soluble drugs, metabolism converts lipid soluble drugs into compounds easier to excrete.
b. drug inactivation: convert active compounds to inactive forms c. inc. therapeutic action: inc effectiveness of some drugs by converting into more active form d. activation of drugs: inactive compound (prodrug) into an active form. e. inc. or dec. toxicity: dec. in toxicity occur when drug converted into inactive form. Inc. occur when drugs transformed into toxic substances. |
|
Factors that influence Metabolism
|
a. age: infants sensitive to drugs until liver matures
b. induction of drug metabolizing enzymes: drugs cause liver to produce drug-metabolizing enzymes through induction. Induction inc metabolism of drugs -> inc doses needed to maintain therapeutic levels. c. first-pass effect: rapid hepatic inactivation of a drug. To prevent use other routes than po. d. nutrition: Cofactors needed for metabolism. e. drug competition: compete with each other for metabolism if use |
|
Steps in Drug Excretion
|
a. glomerular filtration: All drugs except those bound to albumin are filtered through the glomerular membrane.
b. passive tubular reabsorption: lipid-soluble drugs reabsorbed into the blood. Non-lipid soluble drugs (ions, polar) remain in the tubules and excreted in the urine. c. active tubular secretion: Active transport systems pump drugs from blood into the urine. P-glycoprotein, pumps for organic acids/bases |
|
Factors that Affect Renal Drug Excretion
|
a. pH dependent ionization: can speed up excretion of drugs. Changing pH of the urine causes ionization of drugs - reabsorption dec, excretion inc.
b. competition for active tubular transport: competition can delay excretion and prolong the effects of the drug. c. age: infants kidneys not fully developed. Elderly – decline in renal function |
|
Plasma Drug Levels
|
to regulate drug responses. Adjust up or down.
|
|
MEC
|
minimum concentration that is effective – anything below it is not effective.
|
|
Toxic concentration
|
toxicity occurs
|
|
Half-Life
|
time required for amount of drug in body to dec by 50%. Drugs with short half-lives = excreted quickly, long half-lives = excreted more slowly. Half-life determines dosing interval – the time between doses. Long half-life = long time between doses. Short half life = interval between doses shorter
|
|
single dosing
|
plasma levels go up as drug is absorbed. Drug therapeutic at MEC then it will be therapeutic. Plasma levels dec when metabolized and excreted.
|
|
multiple dosing
|
accumulation of drug in the body
|
|
plateau
|
drug level constant – 4 half lives
|
|
loading dose
|
big dose to get their therapeutic level up quickly
|
|
maintenance dose
|
to keep them at therapeutic level
|
|
peak
|
highest level of drug
|
|
trough
|
above minimum therapeutic level
|